Insider Transactions Reported by 42 Insiders of Catalent, Inc.

Location
Somerset, NJ

Sponsored

Quick Takeaways

  • Catalent, Inc. has 42 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are not currently available.

What Changed

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Why This Matters

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Official SEC Source

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 14 Apr 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Catalent, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Peter Zippelius Director $161,451,956 Mixed 27 Oct 2022
John R. Chiminski Executive Chair, Director $8,547,236 Mixed 24 Aug 2022
Steven L. Fasman EVP & Chief Admin Officer $2,691,088 Mixed 23 Aug 2023
Jonathan Arnold SVP, CCO & Div. Head BioP Del. $2,078,213 Mixed 23 Aug 2023
Ricardo Pravda Chief Transformation Officer $1,097,628 Mixed 23 Aug 2023
Madhavan Balachandran Director $1,020,256 Mixed 27 Oct 2023
Christa Kreuzburg Director $921,646 Mixed 25 Jan 2024
Karen Flynn Director $904,924 Mixed 27 Oct 2023
Rosemary A. Crane Director $887,598 Mixed 27 Oct 2023
Michael J. Grippo SVP, Strategy & Corp. Dev. $882,096 Mixed 23 Aug 2023
Thomas P. Castellano SVP, Chief Financial Officer $747,281 Mixed 24 Aug 2022
Kay A. Schmidt SVP, Enterprise Functions $646,486 Mixed 24 Aug 2022
Manja Boerman Pres. BioModalities Division $535,913 Mixed 01 May 2023
Patricia Hunt Pres. Consumer Health Div $418,907 Mixed 16 Oct 2023
Charles Lickfold Svp, Cio $404,965 Mixed 23 Aug 2023
Lorenzo Carletti SVP Global Ops Ph & Cons Hlth $316,216 Mixed 23 Aug 2023
Thomas W. Hawkeswood Pres. Pharma Prod Delivery Div $275,578 Mixed 23 Aug 2023
Michael A. Riley Pres. Bio Product Delivery Div $245,091 Mixed 26 Aug 2022
Ricardo Zayas SVP, Operations, Biologics NA $231,371 Mixed 01 Aug 2023
Mario Gargiulo SVP, Ops, Biologics Europe $211,034 Mixed 01 May 2023
Karen Murphy Santiago VP & Chief Accounting Officer $177,088 Mixed 01 Aug 2023
Ricci S. Whitlow President, CSS $108,677 Mixed 21 Jan 2022
Michelle R. Ryan Director $0 Mixed 18 Dec 2024
Gregory T. Lucier Director $0 Mixed 18 Dec 2024
David McErlane Group President, Biologics $0 Mixed 18 Dec 2024
Donald E. Morel Jr. Director $0 Mixed 18 Dec 2024
Lisa Evoli SVP, Chief HR Officer $0 Mixed 18 Dec 2024
J. Martin Carroll Director $0 Mixed 18 Dec 2024
John J. Greisch Executive Chair, Director $0 Mixed 18 Dec 2024
Scott Gunther SVP, Quality & Reg. Affairs $0 Mixed 18 Dec 2024
Alessandro Maselli President & CEO, Director $0 Mixed 18 Dec 2024
Michael J. Barber Director $0 Mixed 18 Dec 2024
Rolf A. Classon Director $0 Mixed 18 Dec 2024
Jack L. Stahl Director $0 Mixed 18 Dec 2024
Frank A. Damelio Director $0 Mixed 18 Dec 2024
Michael Hatzfeld Chief Accounting Officer $0 Mixed 18 Dec 2024
Stephanie Okey Director $0 Mixed 18 Dec 2024
Joseph Anthony Ferraro SVP, General Counsel, CCO $0 Mixed 18 Dec 2024
Matti Masanovich SVP, Chief Financial Officer $0 Mixed 18 Dec 2024
Aristippos Gennadios Group Pres. Pharma & Consumer $0 Mixed 18 Dec 2024
Steven Barg Director $0 Mixed 18 Dec 2024
Ricky Hopson Pres. BioProduct Delivery, CoS $0 Mixed 18 Dec 2024

Top shareholders of Catalent, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Peter Zippelius
3/4/5
Director
class O/S missing
4,342,441
$161,451,956 27 Oct 2022
John R. Chiminski
3/4/5
Executive Chair, Director
class O/S missing
229,888
$8,547,236 24 Aug 2022
Steven L. Fasman
3/4/5
EVP & Chief Admin Officer
class O/S missing
72,380
$2,691,088 23 Aug 2023
Jonathan Arnold
3/4/5
SVP, CCO & Div. Head BioP Del.
class O/S missing
55,896
$2,078,213 23 Aug 2023
Ricardo Pravda
3/4/5
Chief Transformation Officer
class O/S missing
29,522
$1,097,628 23 Aug 2023
Madhavan Balachandran
3/4/5
Director
class O/S missing
27,441
$1,020,256 27 Oct 2023
Christa Kreuzburg
3/4/5
Director
class O/S missing
18,283
$921,646 25 Jan 2024
Karen Flynn
3/4/5
Director
class O/S missing
24,339
$904,924 27 Oct 2023
Rosemary A. Crane
3/4/5
Director
class O/S missing
23,873
$887,598 27 Oct 2023
Michael J. Grippo
3/4/5
SVP, Strategy & Corp. Dev.
class O/S missing
23,725
$882,096 23 Aug 2023
Thomas P. Castellano
3/4/5
SVP, Chief Financial Officer
class O/S missing
20,099
$747,281 24 Aug 2022
Kay A. Schmidt
3/4/5
SVP, Enterprise Functions
class O/S missing
17,388
$646,486 24 Aug 2022
Manja Boerman
3/4/5
Pres. BioModalities Division
class O/S missing
14,414
$535,913 01 May 2023
Patricia Hunt
3/4/5
Pres. Consumer Health Div
class O/S missing
11,267
$418,907 16 Oct 2023
Charles Lickfold
3/4/5
SVP, CIO
class O/S missing
10,892
$404,965 23 Aug 2023
Lorenzo Carletti
3/4/5
SVP Global Ops Ph & Cons Hlth
class O/S missing
8,505
$316,216 23 Aug 2023
Thomas W. Hawkeswood
3/4/5
Pres. Pharma Prod Delivery Div
class O/S missing
7,412
$275,578 23 Aug 2023
Michael A. Riley
3/4/5
Pres. Bio Product Delivery Div
class O/S missing
6,592
$245,091 26 Aug 2022
Ricardo Zayas
3/4/5
SVP, Operations, Biologics NA
mixed-class rows
16,101
mixed-class rows
$231,371 01 Aug 2023
Mario Gargiulo
3/4/5
SVP, Ops, Biologics Europe
class O/S missing
5,676
$211,034 01 May 2023
Karen Murphy Santiago
3/4/5
VP & Chief Accounting Officer
mixed-class rows
9,979
mixed-class rows
$177,088 01 Aug 2023
Ricci S. Whitlow
3/4/5
President, CSS
class O/S missing
2,923
$108,677 21 Jan 2022
HUNTINGTON NATIONAL BANK
13F
Company
class O/S missing
1
$63 31 Dec 2025
13F
Michael Hatzfeld
3/4/5
Chief Accounting Officer
class O/S missing
3,981
18 Dec 2024

Recent Insider Transactions by Companies or Individuals for Catalent, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.